Evidence map›Paper›PMID 39376878›Full record

ReviewCureus2024

The Science of Solid Lipid Nanoparticles: From Fundamentals to Applications.

Navaneetha Krishnan M, Sangeetha S, Sree Ranjani P, Damodharan Narayanasamy

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Navaneetha Krishnan MPharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, IND.
Sangeetha SPharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, IND.
Sree Ranjani PPharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, IND.
Damodharan NarayanasamyPharmaceutics, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solid lipid nanoparticles (SLNs) play a crucial role in drug delivery, offering benefits such as enhanced bioavailability, targeted distribution, and reduced toxicity. This article provides a comprehensive overview of SLN formulation, development, and advancement in pharmaceutical research, examining their characteristics, classifications, and significance. The review also delves into the real-world applicability of various SLN formulations across different routes of administration, discussing their advantages, disadvantages, and challenges of scalability, along with strategies for efficient implementation. Furthermore, it explores the diverse applications of SLNs through various delivery methods, addressing the obstacles and potential solutions. By highlighting the critical role of SLNs in improving treatment outcomes, this review underscores their importance in modern drug delivery systems.

Indexed as

applications of slnsdrug deliverydrug delivery systemnanocarriersnanostructured lipid carrierssolid lipid nanoparticles (slns)

Identifiers

PMID39376878
PMCPMC11456405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.